DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Brose MS, Worden FP, Newbold KL. et al.
Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory
differentiated thyroid cancer in the Phase III SELECT Trial.
J Clin Oncol 2017;
35: 2692-2699
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.